Does ETELCALCETIDE Cause Peripheral arterial occlusive disease? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Peripheral arterial occlusive disease have been filed in association with ETELCALCETIDE (PARSABIV). This represents 2.3% of all adverse event reports for ETELCALCETIDE.
63
Reports of Peripheral arterial occlusive disease with ETELCALCETIDE
2.3%
of all ETELCALCETIDE reports
17
Deaths
62
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From ETELCALCETIDE?
Of the 63 reports, 17 (27.0%) resulted in death, 62 (98.4%) required hospitalization, and 2 (3.2%) were considered life-threatening.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETELCALCETIDE. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does ETELCALCETIDE Cause?
Underdose (246)
Shunt stenosis (202)
Nausea (182)
Product storage error (148)
Blood parathyroid hormone increased (142)
Hypocalcaemia (140)
Shunt occlusion (126)
Blood calcium decreased (119)
Diarrhoea (107)
Vomiting (102)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
Which ETELCALCETIDE Alternatives Have Lower Peripheral arterial occlusive disease Risk?
ETELCALCETIDE vs ETEPLIRSEN
ETELCALCETIDE vs ETESEVIMAB
ETELCALCETIDE vs ETHACRYNIC ACID
ETELCALCETIDE vs ETHAMBUTOL
ETELCALCETIDE vs ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN